First Wave BioPharma, Inc.
Symbol: FWBI
NASDAQ
2.78
USDDzisiejsza cena rynkowa
-0.2744
Wskaźnik P/E
0.0010
Wskaźnik PEG
5.63M
Kapitalizacja MRK
- 0.00%
Rentowność DIV
First Wave BioPharma, Inc. (FWBI) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 10.3 | 3.7 | 1.4 | 8.2 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.net-receivables | 0.02 | 0 | 0.1 | 0 | ||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.other-current-assets | 4.49 | 1.2 | 2 | 1176268 | ||||||||||
balance-sheet.row.total-current-assets | 14.82 | 5 | 3.4 | 9.4 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 0.98 | 0.2 | 0.3 | 0.4 | ||||||||||
balance-sheet.row.goodwill | 6.74 | 1.7 | 1.7 | 1.9 | ||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 6.74 | 1.7 | 1.7 | 1.9 | ||||||||||
balance-sheet.row.long-term-investments | 0.09 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.tax-assets | -0.06 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.other-non-current-assets | 0.12 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-non-current-assets | 7.86 | 1.9 | 2 | 2.4 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 22.67 | 6.9 | 5.4 | 11.8 | ||||||||||
balance-sheet.row.account-payables | 3.19 | 0.6 | 0.7 | 2.7 | ||||||||||
balance-sheet.row.short-term-debt | 1.41 | 0.7 | 0.7 | 0.7 | ||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.long-term-debt-total | 0.69 | 0.1 | 0.2 | 0.3 | ||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 2.58 | 0.8 | 1.1 | 8 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 0.69 | 0.1 | 0.2 | 7.3 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 0.89 | 0.1 | 0.3 | 0.4 | ||||||||||
balance-sheet.row.total-liab | 12.2 | 3.3 | 2.7 | 19.6 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.retained-earnings | -713.95 | -184.3 | -168.5 | -153.9 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | -1.2 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 724.43 | 187.9 | 171.3 | 147.3 | ||||||||||
balance-sheet.row.total-stockholders-equity | 10.48 | 3.6 | 2.7 | -7.8 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 22.67 | 6.9 | 5.4 | 11.8 | ||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-equity | 10.48 | 3.6 | 2.7 | -7.8 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 22.67 | - | - | - | ||||||||||
Total Investments | 0.09 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-debt | 2.1 | 0.8 | 0.9 | 1 | ||||||||||
balance-sheet.row.net-debt | -8.2 | -2.9 | -0.5 | -7.2 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -15.79 | -15.8 | -14.6 | -58.5 | |||||||||
cash-flows.row.depreciation-and-amortization | 0.03 | 0 | 0 | 0.5 | |||||||||
cash-flows.row.deferred-income-tax | -0.17 | 0.2 | 0 | 3.8 | |||||||||
cash-flows.row.stock-based-compensation | 1.04 | 1 | 0.8 | 1.4 | |||||||||
cash-flows.row.change-in-working-capital | 2.19 | 2.2 | -10.5 | 17.1 | |||||||||
cash-flows.row.account-receivables | 0.09 | 0.1 | -0.1 | 0.6 | |||||||||
cash-flows.row.inventory | 0.75 | 0 | 0.1 | -0.6 | |||||||||
cash-flows.row.account-payables | -0.17 | -0.2 | -2 | 1.4 | |||||||||
cash-flows.row.other-working-capital | 1.51 | 2.3 | -8.5 | 15.7 | |||||||||
cash-flows.row.other-non-cash-items | 0.32 | 0 | 2 | 3.5 | |||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -12.38 | 0 | 0 | 0 | |||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.5 | -0.5 | 0 | -10.3 | |||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.net-cash-used-for-investing-activites | -0.5 | -0.5 | 0 | -10.3 | |||||||||
cash-flows.row.debt-repayment | -0.6 | -0.6 | -0.6 | -507125 | |||||||||
cash-flows.row.common-stock-issued | 9.88 | 15.8 | 23 | 32.7 | |||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 4000000 | |||||||||
cash-flows.row.dividends-paid | 0 | -0.3 | 0 | -4507125 | |||||||||
cash-flows.row.other-financing-activites | 6.04 | 15.4 | -6.6 | 1014262.1 | |||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 15.23 | 15.2 | 15.7 | 44.8 | |||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | -0.3 | 0 | |||||||||
cash-flows.row.net-change-in-cash | 2.35 | 2.3 | -6.9 | 2.2 | |||||||||
cash-flows.row.cash-at-end-of-period | 10.37 | 3.7 | 1.4 | 8.2 | |||||||||
cash-flows.row.cash-at-beginning-of-period | 8.02 | 1.4 | 8.2 | 6.1 | |||||||||
cash-flows.row.operating-cash-flow | -12.38 | -12.4 | -22.3 | -32.3 | |||||||||
cash-flows.row.capital-expenditure | -0.5 | -0.5 | 0 | -10.3 | |||||||||
cash-flows.row.free-cash-flow | -12.88 | -12.9 | -22.3 | -42.6 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.cost-of-revenue | 0.08 | 0 | 0.1 | 0.5 | |||||||||
income-statement-row.row.gross-profit | -0.08 | 0 | -0.1 | -0.5 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 5.03 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 10.74 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | -0.01 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 0 | 0 | -0.2 | 0.5 | |||||||||
income-statement-row.row.operating-expenses | 15.76 | 15.7 | 12.7 | 56.7 | |||||||||
income-statement-row.row.cost-and-expenses | 15.77 | 15.8 | 12.7 | 56.7 | |||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.interest-expense | 0.02 | 0 | 0 | 0 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | -0.01 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | -0.02 | 0 | -2 | 0.5 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | -0.2 | 0.5 | |||||||||
income-statement-row.row.total-operating-expenses | -0.02 | 0 | -2 | 0.5 | |||||||||
income-statement-row.row.interest-expense | 0.02 | 0 | 0 | 0 | |||||||||
income-statement-row.row.depreciation-and-amortization | 0.03 | 0 | -0.2 | 3.4 | |||||||||
income-statement-row.row.ebitda-caps | -15.74 | - | - | - | |||||||||
income-statement-row.row.operating-income | -15.77 | -15.8 | -12.7 | -59.1 | |||||||||
income-statement-row.row.income-before-tax | -15.79 | -15.8 | -14.6 | -58.5 | |||||||||
income-statement-row.row.income-tax-expense | 0.02 | 0 | 2 | 0.5 | |||||||||
income-statement-row.row.net-income | -15.81 | -15.8 | -16.6 | -59.1 |
Często zadawane pytania
Ile wynosi First Wave BioPharma, Inc. (FWBI) aktywów ogółem?
First Wave BioPharma, Inc. (FWBI) całkowite aktywa to 6883195.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.000.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to -8.250.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.000.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.000.
Co to jest First Wave BioPharma, Inc. (FWBI) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi -15794983.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 826844.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 15741553.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 3711770.000.